Cargando…

Tolerogenic citrullinated peptide for arthritis

Detalles Bibliográficos
Autores principales:	Gertel, Smadar, Shoenfeld, Yehuda, Amital, Howard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637280/ https://www.ncbi.nlm.nih.gov/pubmed/26305847

Ejemplares similares

Immunomodulation of RA Patients' PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens
por: Gertel, Smadar, et al.
Publicado: (2017)

Dysregulation of G protein-coupled receptors of the autonomic nervous system, adrenergic and muscarinic acetylcholine receptors, in patients with autoimmune dysautonomic-related disorders
por: Halpert, Gilad, et al.
Publicado: (2020)

Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire
por: Fisher, Benjamin AC, et al.
Publicado: (2012)

Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
por: Abdel Fattah, Nermeen SA, et al.
Publicado: (2009)

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis
por: Pruijn, Ger JM, et al.
Publicado: (2010)

Rheumatology in the Middle East in 2017: clinical challenges and research
por: Watad, Abdulla, et al.
Publicado: (2017)

Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens
por: Fernandes-Cerqueira, Cátia, et al.
Publicado: (2015)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
por: Won, Pureun, et al.
Publicado: (2021)

Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)

The utility of PET/CT in large vessel vasculitis
por: Ben Shimol, Jennifer, et al.
Publicado: (2020)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
por: Pfeil, Jennifer, et al.
Publicado: (2020)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Citrullinated Peptides as a Substrate for the Detection of Rheumatoid Arthritis-Specific Autoantibodies
por: van Venrooij, Walther J
Publicado: (2000)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
por: Hamooda, Mohamed, et al.
Publicado: (2016)

Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting
por: Selmi, Carlo, et al.
Publicado: (2014)

Editorial for “Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form”
por: Dotan, Arad, et al.
Publicado: (2023)

Anti-citrullinated protein antibodies in rheumatoid arthritis: a bridge between genetic predisposition and autoimmunity
por: Kim, Hae-Rim
Publicado: (2013)

Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis
por: Li, Chun, et al.
Publicado: (2019)

Peptides reloaded - new strategies for tolerogenic vaccination
por: Hamann, Alf, et al.
Publicado: (2011)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
por: Vignesh, Ammapati Paul Pandian, et al.
Publicado: (2015)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
por: Tebo, Anne E, et al.
Publicado: (2012)

Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
por: El-Banna, Hassan, et al.
Publicado: (2014)

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
por: Mohamad, Wan Majdiah Wan, et al.
Publicado: (2018)

Anti–Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications
por: Mekic, Mevludin, et al.
Publicado: (2020)

Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis
por: Song, Jing, et al.
Publicado: (2021)

Association of Interleukin-10 Genotypes and Anticyclic Citrullinated Peptide Antibodies with Rheumatoid Arthritis
por: Moghimi, Nasrin, et al.
Publicado: (2022)

Salivary anti-cyclic citrullinated peptide as a screening tool for rheumatoid arthritis
por: Mortazavi, Nazanin, et al.
Publicado: (2022)

Classical Examples of the Concept of the ASIA Syndrome
por: Borba, Vânia, et al.
Publicado: (2020)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?
por: Ruscitti, Piero, et al.
Publicado: (2023)

Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
por: Pruijn, Ger J. M.
Publicado: (2015)

Role of Citrullinated Collagen in Autoimmune Arthritis
por: Myers, Linda K., et al.
Publicado: (2022)

Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides
Publicado: (1990)

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
por: Pfeil, Jennifer, et al.
Publicado: (2021)

The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis
por: Shovman, O., et al.
Publicado: (2005)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
por: Alexiou, Ioannis, et al.
Publicado: (2007)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
por: Vavrinec, J, et al.
Publicado: (2002)

The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients
por: Jearn, La-He, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1bal872tt6ru627fem0o9f9nf2